CD274 and cancer: The expression of PD-L1 may not predict therapeutic efficacy because the interactions between PD-1 and PD-L1 on B-cells link the adaptive and innate immune systems, which may explain the changes in PD-1/PD-L1 response to cancer during cancer treatment9.